Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro
β Scribed by Casey L. Moulson; Albert J.T. Millis
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 578 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract To dissect the effect of hyperinsulinemia versus hyperglycemia on TNFβrelated apoptosis inducing ligand (TRAIL) expression in the macrovascular district, we measured TRAIL mRNA and protein in four groups of animals: streptozotocin (SZT)βinduced diabetic rats, vehicleβtreated control ani
## Abstract The process of vascular calcification presents several features similar to osteogenesis in which fibronectin (FN) acts as a regulator of osteoblastic differentiation and the ERK signal pathway is involved. In order to find whether FN promotes the osteoblastic differentiation of vascular
Expression of both basic fibroblast growth factor (bFGF) and FGF receptors (FGFR) by vascular smooth muscle cells suggests that autocrine FGF signaling mechanisms may have important functions. Inhibition of smooth muscle cell bFGF expression provokes apoptosis, suggesting that endogenous bFGF genera
Aberrant vascular smooth muscle cell (VSMC) hyperplasia is the hallmark of atherosclerosis and restenosis seen after vascular surgery. Heparin inhibits VSMC proliferation in animal models and in cell culture. To test our hypothesis that heparin mediates its antiproliferative effect by altering phosp
## Abstract The A~2B~ adenosine receptor (A~2B~AR) has been described to control various vascular functions, including inhibition of smooth muscle cell proliferation. Here, we sought to understand the regulation of __A__~__2B__~__AR__ gene expression in aortic vascular smooth muscle cells (VSMCs),